Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa

Soledad Lange, Ibeth Gonzalez, Mauricio P. Pinto, Maximiliano Arce, Rodrigo Valenzuela, Evelyn Aranda, Matias Elliot, Marjorie Alvarez, Soledad Henriquez, Ethel V. Velasquez, Felipe Orge, Barbara Oliva, Pamela Gonzalez, Manuel Villalon, Kelly M. Cautivo, Alexis M. Kalergis, Karla Pereira, Camila Mendoza, Claudia Saez, Sumie KatoMauricio A. Cuello, Fernanda Parborell, Griselda Irusta, Veronica Palma, Miguel L. Allende, Gareth I. Owen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Knockout models have shown that the coagulation system has a role in vascular development and angiogenesis. Herein, we report for the first time that zymogen FX and its active form (FXa) possess anti-angiogenic properties. Both the recombinant FX and FXa inhibit angiogenesis in vitro using endothelial EA.hy926 and human umbilical cord vascular endothelial cells (HUVEC). This effect is dependent on the Gla domain of FX. We demonstrate that FX and FXa use different mechanisms: the use of Rivaroxaban (RX) a specific inhibitor of FXa attenuated its anti-angiogenic properties but did not modify the anti-angiogenic effect of FX. Furthermore, only the anti-angiogenic activity of FXa is PAR-1dependent. Using in vivo models, we show that FX and FXa are anti-angiogenic in the zebrafish intersegmental vasculature (ISV) formation and in the chick embryo chorioallantoic membrane (CAM) assays. Our results provide further evidence for the non-hemostatic functions of FX and FXa and demonstrate for the first time a biological role for the zymogen FX. J. Cell. Physiol. 229: 1673-1680, 2014.

Original languageEnglish (US)
Pages (from-to)1673-1680
Number of pages8
JournalJournal of Cellular Physiology
Volume229
Issue number11
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Factor X
Enzyme Precursors
Factor Xa
Chorioallantoic Membrane
Umbilical Cord
Endothelial cells
Zebrafish
Chick Embryo
Coagulation
Blood Vessels
Assays
Endothelial Cells
Membranes
Rivaroxaban
In Vitro Techniques

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Lange, S., Gonzalez, I., Pinto, M. P., Arce, M., Valenzuela, R., Aranda, E., ... Owen, G. I. (2014). Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa. Journal of Cellular Physiology, 229(11), 1673-1680. https://doi.org/10.1002/jcp.24612

Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa. / Lange, Soledad; Gonzalez, Ibeth; Pinto, Mauricio P.; Arce, Maximiliano; Valenzuela, Rodrigo; Aranda, Evelyn; Elliot, Matias; Alvarez, Marjorie; Henriquez, Soledad; Velasquez, Ethel V.; Orge, Felipe; Oliva, Barbara; Gonzalez, Pamela; Villalon, Manuel; Cautivo, Kelly M.; Kalergis, Alexis M.; Pereira, Karla; Mendoza, Camila; Saez, Claudia; Kato, Sumie; Cuello, Mauricio A.; Parborell, Fernanda; Irusta, Griselda; Palma, Veronica; Allende, Miguel L.; Owen, Gareth I.

In: Journal of Cellular Physiology, Vol. 229, No. 11, 2014, p. 1673-1680.

Research output: Contribution to journalArticle

Lange, S, Gonzalez, I, Pinto, MP, Arce, M, Valenzuela, R, Aranda, E, Elliot, M, Alvarez, M, Henriquez, S, Velasquez, EV, Orge, F, Oliva, B, Gonzalez, P, Villalon, M, Cautivo, KM, Kalergis, AM, Pereira, K, Mendoza, C, Saez, C, Kato, S, Cuello, MA, Parborell, F, Irusta, G, Palma, V, Allende, ML & Owen, GI 2014, 'Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa', Journal of Cellular Physiology, vol. 229, no. 11, pp. 1673-1680. https://doi.org/10.1002/jcp.24612
Lange S, Gonzalez I, Pinto MP, Arce M, Valenzuela R, Aranda E et al. Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa. Journal of Cellular Physiology. 2014;229(11):1673-1680. https://doi.org/10.1002/jcp.24612
Lange, Soledad ; Gonzalez, Ibeth ; Pinto, Mauricio P. ; Arce, Maximiliano ; Valenzuela, Rodrigo ; Aranda, Evelyn ; Elliot, Matias ; Alvarez, Marjorie ; Henriquez, Soledad ; Velasquez, Ethel V. ; Orge, Felipe ; Oliva, Barbara ; Gonzalez, Pamela ; Villalon, Manuel ; Cautivo, Kelly M. ; Kalergis, Alexis M. ; Pereira, Karla ; Mendoza, Camila ; Saez, Claudia ; Kato, Sumie ; Cuello, Mauricio A. ; Parborell, Fernanda ; Irusta, Griselda ; Palma, Veronica ; Allende, Miguel L. ; Owen, Gareth I. / Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa. In: Journal of Cellular Physiology. 2014 ; Vol. 229, No. 11. pp. 1673-1680.
@article{9d2ffc61db2049ff9f81ffb2c276eabe,
title = "Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa",
abstract = "Knockout models have shown that the coagulation system has a role in vascular development and angiogenesis. Herein, we report for the first time that zymogen FX and its active form (FXa) possess anti-angiogenic properties. Both the recombinant FX and FXa inhibit angiogenesis in vitro using endothelial EA.hy926 and human umbilical cord vascular endothelial cells (HUVEC). This effect is dependent on the Gla domain of FX. We demonstrate that FX and FXa use different mechanisms: the use of Rivaroxaban (RX) a specific inhibitor of FXa attenuated its anti-angiogenic properties but did not modify the anti-angiogenic effect of FX. Furthermore, only the anti-angiogenic activity of FXa is PAR-1dependent. Using in vivo models, we show that FX and FXa are anti-angiogenic in the zebrafish intersegmental vasculature (ISV) formation and in the chick embryo chorioallantoic membrane (CAM) assays. Our results provide further evidence for the non-hemostatic functions of FX and FXa and demonstrate for the first time a biological role for the zymogen FX. J. Cell. Physiol. 229: 1673-1680, 2014.",
author = "Soledad Lange and Ibeth Gonzalez and Pinto, {Mauricio P.} and Maximiliano Arce and Rodrigo Valenzuela and Evelyn Aranda and Matias Elliot and Marjorie Alvarez and Soledad Henriquez and Velasquez, {Ethel V.} and Felipe Orge and Barbara Oliva and Pamela Gonzalez and Manuel Villalon and Cautivo, {Kelly M.} and Kalergis, {Alexis M.} and Karla Pereira and Camila Mendoza and Claudia Saez and Sumie Kato and Cuello, {Mauricio A.} and Fernanda Parborell and Griselda Irusta and Veronica Palma and Allende, {Miguel L.} and Owen, {Gareth I.}",
year = "2014",
doi = "10.1002/jcp.24612",
language = "English (US)",
volume = "229",
pages = "1673--1680",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa

AU - Lange, Soledad

AU - Gonzalez, Ibeth

AU - Pinto, Mauricio P.

AU - Arce, Maximiliano

AU - Valenzuela, Rodrigo

AU - Aranda, Evelyn

AU - Elliot, Matias

AU - Alvarez, Marjorie

AU - Henriquez, Soledad

AU - Velasquez, Ethel V.

AU - Orge, Felipe

AU - Oliva, Barbara

AU - Gonzalez, Pamela

AU - Villalon, Manuel

AU - Cautivo, Kelly M.

AU - Kalergis, Alexis M.

AU - Pereira, Karla

AU - Mendoza, Camila

AU - Saez, Claudia

AU - Kato, Sumie

AU - Cuello, Mauricio A.

AU - Parborell, Fernanda

AU - Irusta, Griselda

AU - Palma, Veronica

AU - Allende, Miguel L.

AU - Owen, Gareth I.

PY - 2014

Y1 - 2014

N2 - Knockout models have shown that the coagulation system has a role in vascular development and angiogenesis. Herein, we report for the first time that zymogen FX and its active form (FXa) possess anti-angiogenic properties. Both the recombinant FX and FXa inhibit angiogenesis in vitro using endothelial EA.hy926 and human umbilical cord vascular endothelial cells (HUVEC). This effect is dependent on the Gla domain of FX. We demonstrate that FX and FXa use different mechanisms: the use of Rivaroxaban (RX) a specific inhibitor of FXa attenuated its anti-angiogenic properties but did not modify the anti-angiogenic effect of FX. Furthermore, only the anti-angiogenic activity of FXa is PAR-1dependent. Using in vivo models, we show that FX and FXa are anti-angiogenic in the zebrafish intersegmental vasculature (ISV) formation and in the chick embryo chorioallantoic membrane (CAM) assays. Our results provide further evidence for the non-hemostatic functions of FX and FXa and demonstrate for the first time a biological role for the zymogen FX. J. Cell. Physiol. 229: 1673-1680, 2014.

AB - Knockout models have shown that the coagulation system has a role in vascular development and angiogenesis. Herein, we report for the first time that zymogen FX and its active form (FXa) possess anti-angiogenic properties. Both the recombinant FX and FXa inhibit angiogenesis in vitro using endothelial EA.hy926 and human umbilical cord vascular endothelial cells (HUVEC). This effect is dependent on the Gla domain of FX. We demonstrate that FX and FXa use different mechanisms: the use of Rivaroxaban (RX) a specific inhibitor of FXa attenuated its anti-angiogenic properties but did not modify the anti-angiogenic effect of FX. Furthermore, only the anti-angiogenic activity of FXa is PAR-1dependent. Using in vivo models, we show that FX and FXa are anti-angiogenic in the zebrafish intersegmental vasculature (ISV) formation and in the chick embryo chorioallantoic membrane (CAM) assays. Our results provide further evidence for the non-hemostatic functions of FX and FXa and demonstrate for the first time a biological role for the zymogen FX. J. Cell. Physiol. 229: 1673-1680, 2014.

UR - http://www.scopus.com/inward/record.url?scp=84904893895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904893895&partnerID=8YFLogxK

U2 - 10.1002/jcp.24612

DO - 10.1002/jcp.24612

M3 - Article

C2 - 24615682

AN - SCOPUS:84904893895

VL - 229

SP - 1673

EP - 1680

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 11

ER -